Abstract
In 2006, the European market for interventional cardiology was valued at over
(E) 1.4 billion. This value represents the market for coronary stents, PTCA
balloons, interventional catheters, interventional guidewires, introducer
sheaths, IVUS catheters, brackytherapy catheters, embolic protection devices,
and diagnostic catheters and guidewires. The European market, as defined in
this report, encompasses germany, France, Italy, United Kingdom (U.K.), Spain,
Benelux (Belgium, Netherlands, and Luxemburg), Scandanavia (Finland, Denmark,
Sweden, and Norway), Switzerland, Audtria, Portugal, and Poland.
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
- 1.1 EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
- 1.2 TREND ANALYSIS BY COUNTRY
- 1.3 PROCEDURE NUMBERS
- 1.4 COUNTRY PROFILE
- 1.4.1 Population
- 1.4.2 GDP per Capita
- 1.4.3 PCI and DES Penetration Rates
- 1.4.4 Price Index
- 1.5 CORONARY STENTS
- 1.6 PTCA BALLOONS
- 1.7 INTERVENTIONAL CATHETERS
- 1.8 INTERVENTIONAL GUIDEWIRES
- 1.9 INTROD UCER SHEATHS
- 1.10 IVUS CATHETERS
- 1.11 BRACHY THERAPY CATHETERS
- 1.12 EMBOLIC PROTECTION DEVICES
- 1.13 DIAGNOSTIC CATHETERS AND GUIDEWIRES
- 1.14 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
- 2.1 RESEARCH SCOPE
- 2.2 IDATAS 9 STEP METHODOLOGY
- Step 1 : Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Survey design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecasting
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
- 3.1 INTRODUCTION
- 3.2 CURRENCY EXCHANGE RATE
- 3.3 OVERVIEW OF THE MARKET
- 3.4 TREND ANALYSIS BY COUNTRY
- 3.5 MARKET DRIVERS
- 3.5.1 Changes in the Healthcare System
- 3.5.2 DESMarket
- 3.5.3 Demographics
- 3.6 MARKET LIMITERS
- 3.6.1 Budget Constraints
- 3.6.2 Price Erosion
- 3.6.3 Late-Stent Thrombosis
- 3.7 COMPETITIVE ANALYSIS
- 3.7.1 Market Concentration
- 3.8 MERGERS AND ACQUISITIONS
- 3.8.1 Boston Scientific Acquires Guidant
- 3.8.2 Abbott Laboratories Acquires Guidant' s Interventional Cardiology Division
- 3.8.3 Johnson & Johnson Agrees to Acquire Conor Medsystems
- 3.8.4 Future Acquisitions
- 3.9 LITIGATION ISSUES
- 3.10 EMERGING MARKETS
- 3.11 POTENTIAL MARKET: VULNERABLE PLAQUE
- 3.12 MARKET HIGHLIGHTS
- 3.12.1 Abbott Laboratories Introduces Xience
- 3.12.2 Xtent Prepares to Enter the European Market
- 3.12.3 B. Braun Releases New DES
PROCEDURE NUMBERS
- 4.1 TOTAL PROCEDURE NUMBERS
- 4.2 GERMANY
- 4.3 FRANCE
- 4.4 ITALY
- 4.5 UNITED KINGDOM
- 4.6 SPAIN
- 4.7 BENELUX
- 4.7.1 Belgium
- 4.7.2 Netherlands
- 4.8 SCANDINAVIA
- 4.9 SWITZERLAND
- 4.10 AUSTRIA
- 4.11 PORTUGAL
- 4.12 POLAND
COUNTRY PROFILES
- 5.1 INTRODUCTION
- 5.1.1 Population
- 5.1.2 GDP per Capita
- 5.1.3 PCI and DES Penetration Rates
- 5.1.4 Price Index
- 5.2 GERMANY
- 5.3 FRANCE
- 5.4 ITALY
- 5.5 UNITED KINGDOM
- 5.6 SPAN
- 5.7 BENELUX
- 5.8 SCANDINAVIA
- 5.9 SWITZERLAND
- 5.10 AUSTRIA
- 5.11 PORTUGAL
- 5.12 POLAND
BARE-METAL AND DRUG-ELUTNG STENTS
- 6.1 INTRODUCTION
- 6.2 OVERVIEW OF THE MARKET
- 6.2.1 Market Analysis and Forecast
- 6.2.2 Bare-Metal versus Drug-Eluting Stents
- 6.2.3 Bare-Metal Stent Market
- 6.2.4 Drug-Eluting Stent Market
- 6.2.5 Market Drivers
- 6.2.6 Market Limiters
- 6.3 GERMANY
- 6.3.1 Bare-Metal Stent Market
- 6.3.2 Drug-Eluting Stent Market
- 6.4 FRANCE
- 6.4.1 Bare-Metal Stent Market
- 6.4.2 Drug-Eluting Stent Market
- 6.5 ITALY
- 6.5.1 Bare-Metal Stent Market
- 6.5.2 Drug-Eluting Stent Market
- 6.6 UNITED KINGDOM
- 6.6.1 Bare-Metal Stent Market
- 6.6.2 Drug-Eluting Stent Market
- 6.7 SPAIN
- 6.7.1 Bare-Metal Stent Market
- 6.7.2 Drug-Eluting Stent Market
- 6.8 BENELUX
- 6.8.1 Bare-Metal Stent Market
- 6.8.2 Drug-Eluting Stent Market
- 6.9 SCANDINAVIA
- 6.9.1 Bare-Metal Stent Market
- 6.9.2 Drug-Eluting Stent Market
- 6.10 SWITZERLAND
- 6.10.1 Bare-Metal Stent Market
- 6.10.2 Drug-Eluting Stent Market
- 6.11 AUSTRIA
- 6.11.1 Bare-Metal Stent Market
- 6.11.2 Drug-Eluting Stent Market
- 6.12 PORTUGAL
- 6.12.1 Bare-Metal Stent Market
- 6.12.2 Drug-Eluting Stent Market
- 6.13 POLAND
- Bare-Metal Stent Market
- 6.13.2 Drug-Eluting Stent Market
PTCA BALLOON CATHETERS
- 7.1 INTRODUCTION
- 7.2 OVERVIEW OF THE MARKET
- 7.2.1 Market Analysis and Forecast
- 7.2.2 Market Drivers
- 7.2.3 Market Limiters
- 7.2.4 Competitive Analysis
- 7.3 GERMANY
- 7.3.1 Market Analysis and Forecast
- 7.3.2 Competitive Analysis
- 7.4 FRANCE
- 7.4.1 Market Analysis and Forecast
- 7.4.2 Competitive Analysis
- 7.5 ITALY
- 7.5.1 Market Analysis and Forecast
- 7.5.2 Competitive Analysis
- 7.6 UNITED KINGDOM
- 7.6.1 Market Analysis and Forecast
- 7.6.2 Competitive Analysis
- 7.7 SPAIN
- 7.7.1 Market Analysis and Forecast
- 7.7.2 Competitive Analysis
- 7.8 BENELUX
- 7.8.1 Market Analysis and Forecast
- 7.8.2 Competitive Analysis
- 7.9 SCANDINAVIA
- 7.9.1 Market Analysis and Forecast
- 7.9.2 Competitive Analysis
- 7.10 SWITZERLAND
- 7.10.1 Market Analysis and Forecast
- 7.10.2 Competitive Analysis
- 7.11 AUSTRIA
- 7.11.1 Market Analysis and Forecast
- 7.11.2 Competitive Analysis
- 7.12 PORTUGAL
- 7.12.1 Market Analysis and Forecast
- 7.12.2 Competitive Analysis
- 7.13 POLAND
- 7.13.1 Market Analysis and Forecast
- 7.13.2 Competitive Analysis
INTERVENTIONAL CATHETERS
- 8.1 INTRODUCTION
- 8.2 OVERVIEW OF THE MARKET
- 8.2.1 Market Analysis and Forecast
- 8.2.2 Market Drivers
- 8.2.3 Market Limiters
- 8.2.4 Competitive Analysis
- 8.3 GERMANY
- 8.3.1 Market Analysis and Forecast
- 8.3.2 Competitive Analysis
- 8.4 FRANCE
- 8.4.1 Market Analysis and Forecast
- 8.4.2 Competitive Analysis
- 8.5 ITALY
- 8.5.1 Market Analysis and Forecast
- 8.5.2 Competitive Analysis
- 8.6 UNITED KINGDOM
- 8.6.1 Market Analysis and Forecast
- 8.6.2 Competitive Analysis
- 8.7 SPAIN
- 8.7.1 Market Analysis and Forecast
- 8.7.2 Competitive Analysis
- 8.8 BENELUX
- 8.8.1 Market Analysis and Forecast
- 8.8.2 Competitive Analysis
- 8.9 SCANDINAVIA
- 8.9.1 Market Analysis and Forecast
- 8.9.2 Competitive Analysis
- 8.10 SWITZERLAND
- 8.10.1 Market Analysis and Forecast
- 8.10.2 Competitive Analysis
- 8.11 AUSTRIA
- 8.11.1 Market Analysis and Forecast
- 8.11.2 Competitive Analysis
- 8.12 PORTUGAL
- 8.12.1 Market Analysis and Forecast
- 8.12.2 Competitive Analysis
- 8.13 POLAND
- 8.13.1 Market Analysis and Forecast
- 8.13.2 Competitive Analysis
INTERVENTIONAL GUIDEWIRES
- 9.1 INTRODUCTION
- 9.2 OVERVIEW OF THE MARKET
- 9.2.1 Market Analysis and Forecast
- 9.2.2 Market Drivers
- 9.2.3 Market Limiters
- 9.2.4 Competitive Analysis
- 9.3 GERMANY
- 9.3.1 Market Analysis and Forecast
- 9.3.2 Competitive Analysis
- 9.4 FRANCE
- 9.4.1 Market Analysis and Forecast
- 9.4.2 Competitive Analysis
- 9.5 ITALY
- 9.5.1 Market Analysis and Forecast
- 9.5.2 Competitive Analysis
- 9.6 UNITED KINGDOM
- 9.6.1 Market Analysis and Forecast
- 9.6.2 Competitive Analysis
- 9.7 SPAIN
- 9.7.1 Market Analysis and Forecast
- 9.7.2 Competitive Analysis
- 9.8 BENELUX
- 9.8.1 Market Analysis and Forecast
- 9.8.2 Competitive Analysis
- 9.9 SCANDINAVIA
- 9.9.1 Market Analysis and Forecast
- 9.9.2 Competitive Analysis
- 9.10 SWITZERLAND
- 9.10.1 Market Analysis and Forecast
- 9.10.2 Competitive Analysis
- 9.11 AUSTRIA
- 9.11.1 Market Analysis and Forecast
- 9.11.2 Competitive Analysis
- 9.12 PORTUGAL
- 9.12.1 Market Analysis and Forecast
- 9.12.2 Competitive Analysis
- 9.13 POLAND
- 9.13.1 Market Analysis and Forecast
- 9.13.2 Competitive Analysis
INTRODUCER SHEATHS
- 10.1 INTRODUCTION
- 10.2 OVERVIEW OF THE MARKET
- 10.2.1 Market Analysis and Forecast
- 10.2.2 Market by Country
- 10.2.3 Femoral Market
- 10.2.4 Transradial/Brachial Market
- 10.3 MARKET DRIVERS AND LIMITERS
- 10.3.1 Market Drivers
- 10.3.2 Market Limiters
- 10.4 COMPETITIVE ANALYSIS
IVUS CATHETERS
- 11.1 INTRODUCTION
- 11.2 OVERVIEW OF THE MARKET
- 11.2.1 Market Analysis and Forecast
- 11.2.2 Market by Country
- 11.3 MARKET DRIVERS AND LIMITERS
- 11.3.1 Market Drivers
- 11.3.2 Market Limiters
- 11.4 COMPETITIVE ANALYSIS
BRACHY THERAPY CATHETERS
- 12.1 INTRODUCTION
- 12.2 OVERVIEW OF THE MARKET
- 12.2.1 Market Analysis and Forecast
- 12.2.2 Market by Country
- 12.3 MARKET DRIVERS AND LIMITERS
- 12.3.1 Market Drivers
- 12.3.2 Market Limiters
- 12.4 COMPETITIVE ANALYSIS
EMBOLIC PROTECTION DEVICES
- 13.1 INTRODUCTION
- 13.1.1 Application
- 13.1.2 Protection Mechanism
- 13.2 OVERVIEW OF THE MARKET
- 13.2.1 Market Analysis and Forecast
- 13.2.2 Market by Country
- 13.3 MARKET DRIVERS AND LIMITERS
- 13.3.1 Market Drivers
- 13.3.2 Market Limiters
- 13.4 COMPETITIVE ANALYSIS
DIAGNOSTIC CATHETERS AND GUIDEWIRES
- 14.1 INTRODUCTION
- 14.1.1 Diagnostic Procedures: Angiographies
- 14.2 OVERVIEW OF THE MARKET
- 14.2.1 Market Analysis and Forecast
- 14.2.2 Market by Country
- 14.3 DIAGNOSTIC CATHETERS
- 14.3.1 Market Analysis and Forecast
- 14.4 DIAGNOSTIC GUIDEWIRES
- 14.4.1 Market Analysis and Forecast
- 14.5 MARKET DRIVERS AND LIMITERS
- 14.5.1 Market Drivers
- 14.5.2 Market Limiters
- 14.6 COMPETITIVE ANALYSIS
VULNERABLE PLAQUE DEVICES
- 15.1 INTRODUCTION
- 15.2 TARGET POPULATION
- 15.3 POTENTIAL MARKET: BEST-CASE SCENARIO
- 15.4 SCREENING MARKET
- 15.4.1 Market Analysis and Forecast: Best-Case Scenario
- 15.5 INTERVENTIONAL MARKET
- 15.5.1 Market Analysis and Forecast: Best-Case Scenario
- 15.6 TOTAL REVENUE PROBABILITY : SCREENING & INTERVENTIONAL MARKETS
- 15.7 COMPETITIVE ANALYSIS
- 15.7.1 InfraRedX
- 15.7.2 Volcano Therapeutics
- 15.7.3 Bristol-Myers Squibb
- 15.7.4 Medeikon
- 15.7.5 Cryocath
- 15.7.6 Miravant Technologies
- 15.7.7 Boston Scientific
- 15.7.8 Abbott Laboratories
- 15.7.9 Cordis
- 15.7.10 Medtronic
ABBREVIATIONS
LIST OF FIGURES
- Figure 1-1 Market Drivers and Limiters, European Market for PTCA Balloon
Catheters, 2006
- Figure 3-1 Exchange Rate betw een European Currencies and the U.S. Dollar
(US$), 2006
- Figure 3-2 European Market for Interventional Cardiology, Segmented by
Device Type, 2003 - 2013(€)
- Figure 3-3 European Market for Interventional Cardiology, Segmented by
Device Type, 2003 - 2013(US$)
- Figure 3-4 European Market for Interventional Cardiology, Segmented by
Country, 2003 - 2013(€)
- Figure 3-5 European Market for Interventional Cardiology, Segmented by
Country, 2003 - 2013(US$)
- Figure 3-6 Market Drivers, European Market for Interventional Cardiology,
2006
- Figure 3-7 Market Limiters, European Market for Interventional Cardiology
, 2006
- Figure 3-8 Leading Competitors, European Market for Interventional
Cardiology, 2006
- Figure 3-9 Market Concentration based on the Herfindahl Index, European
Market for Interventional Cardiology, 2003 - 2013
- Figure 4-1 Angioplasty Procedures, European Market for Interventional
Cardiology, 2003 - 2013
- Figure 4-2 Angiography Procedures, European Market for Interventional
Cardiology, 2003 - 2013
- Figure 4-3 Angioplasty and Angiography Procedures, German Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-4 Angioplasty and Angiography Procedures, French Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-5 Angioplasty and Angiography Procedures, Italian Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-6 Angioplasty and Angiography Procedures, U.K. Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-7 Angioplasty and Angiography Procedures, Spanish Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-8 Angioplasty and Angiography Procedures, Beneluxian Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-9 Angioplasty and Angiography Procedures, Belgium Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-10 Angioplasty and Angiography Procedures, Dutch Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-11 Angioplasty and Angiography Procedures, Scandinavian Market
for Interventional Cardiology, 2003 - 2013
- Figure 4-12 Angioplasty and Angiography Procedures, Swiss Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-13 Angioplasty and Angiography Procedures, Austrian Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-14 Angioplasty and Angiography Procedures, Portuguese Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-15 Angioplasty and Angiography Procedures, Polish Market for
Interventional Cardiology, 2003 - 2013
- Figure 5-1 Country Indicators, 2006
- Figure 6-1 European Market for Coronary Stents by Type, 2003 - 2013(€)
- Figure 6-2 European Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-3 European Market for Coronary Stents by Country, 2003 -
2013(€)
- Figure 6-4 European Market for Coronary Stents by Country, 2003 - 2013(US$)
- Figure 6-5 Penetration Rate for Coronary Stents by Type, Units Sold, 2003
- 2013
- Figure 6-6 European Market for Bare-Metal Stents by Country, Stents by
Country, 2003 - 2013(€)
- Figure 6-7 European Market for Bare-Metal Stents by Country, 2003 - 2013
(US$)
- Figure 6-8 Leading Competitors, European Market for Bare-Metal Stents, 2006
- Figure 6-9 European Market for Drug-Eluting Stents by Country, 2003 -
2013(€)
- Figure 6-10 European Market for Drug-Eluting Stents by Country, 2003 -
2013(US$)
- Figure 6-11 Leading Competitors, European Market for Drug-Eluting Stents,
2006
- Figure 6-12 Market Drivers and Limiters, European Market for Coronary
Stents, 2006
- Figure 6-13 German Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-14 German Market for Coronary Stents, 2003 - 2013
- Figure 6-15 German Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-16 German Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-17 German Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-18 Leading Competitors, German Market for Bare-Metal Stents, 2006
- Figure 6-19 German Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-20 German Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-21 Leading Competitors, German Market for Drug-Eluting Stents,
2006
- Figure 6-22 French Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-23 French Market for Coronary Stents by Type, 2003 - 2013 (€)
- Figure 6-24 French Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-25 French Market for Coronary Stents, 2003 - 2013(US$)
- Figure 6-26 French Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-27 Leading Competitors, French Market for Bare-Metal Stents, 2006
- Figure 6-28 French Market for Drug-Eluting-Stents, , 2003 - 2013(€)
- Figure 6-29 French Market for Drug-Eluting Stents, , 2003 - 2013(US$)
- Figure 6-30 Leading Competitors, French Market for Drug-Eluting Stents,
2006
- Figure 6-31 Italian Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-32 Italian Market for Coronary Stents by Type, 2003 - 2013(€)
- Figure 6-33 Italian Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-34 Italian Market for Bare-Metal Stents, 2003 - 2013 (€)
- Figure 6-35 Italian Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-36 Leading Competitors, Italian Market for Bare-Metal Stents, 2006
- Figure 6-37 Italian Market for Drug-Eluting-Stents, 2006
- Figure 6-38 Italian Market for Drug-Eluting Stents, 2003 - 2013(US$)
- Figure 6-39 Leading Competitors, Italian Market for Drug-Eluting Stents,
2006
- Figure 6-40 U.K. Market for Coronary Stents by Type, 2003 - 2013
- Figure 6-41 U.K. Market for Coronary Stents by Type, 2003 - 2013 (€)
- Figure 6-42 U.K. Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-43 U.K. Market for Coronary Stents by Type, 2003 - 2013(£)
- Figure 6-44 U.K. Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-45 U.K. Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-46 U.K. Market for Bare-Metal Stents, 2003-2013(£)
- Figure 6-47 Leading Competitors, U.K. Market for Bare-Metal Stents, 2006
- Figure 6-48 U.K. Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-49 U.K. Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-50 U.K. Market for Drug-Eluting-Stents, 2003 - 2013(£)
- Figure 6-51 Leading Competitors, U.K. Market for Drug-Eluting Stents, 2006
- Figure 6-52 Spanish Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-53 Spanish Market for Coronary Stents by Type, 2003 - 2013(€)
- Figure 6-54 Spanish Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-55 Spanish Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-56 Spanish Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-57 Leading Competitors, Spanish Market for Bare-Metal Stents, 2006
- Figure 6-58 Spanish Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-59 Spanish Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-60 Leading Competitors, Spanish Market for Drug-Eluting Stents,
2006
- Figure 6-61 Beneluxian Market for Coronary Stents, Units per PCI
Procedure, 2003 - 2013
- Figure 6-62 Belgian Market for Coronary Stents, Units per PCI Procedure,
2013 - 2013
- Figure 6-63 Dutch Market for Coronary Stents, Units per PCI Procedure,
2013 - 2013
- Figure 6-64 Beneluxian Market for Coronary Stents by Type, 2003 - 2013
(€)
- Figure 6-65 Beneluxian Market for Coronary Stents by Type, 2003 - 2013
(US$)
- Figure 6-66 Beneluxian Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-67 Beneluxian Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-70 Dutch Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-71 Dutch Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-72 Leading Competitors, Beneluxian Market for Bare-Metal Stents,
2006
- Figure 6-73 Beneluxian Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-74 Beneluxian Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-79 Leading Competitors, Beneluxian Market for Drug-Eluting
Stents, 2006
- Figure 6-80 Scandinavian Market for Coronary Stents, Units per PCI
Procedure, 2003 - 2013
- Figure 6-83 Scandinavian Market for Coronary Stents, Units per PCI
Procedure, 2003 - 2013
- Figure 6-84 Scandinavian for Bare-Metal Stents, 2003 - 2013 (US$), 2003 -
2013 (US$)
- Figure 6-85 Leading Competitors, Scandinavian Market for Bare-Metal
Stents, 2006
- Figure 6-86 Scandinavian Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-87 Scandinavian Market for Drug-Eluting Stents, 2006
- Figure 6-88 Leading Competitors, Scandinavian Market for Drug-Eluting
Stents, 2006
- Figure 6-89 Swiss Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-91 Swiss Market for Coronary Swiss Market for Coronary Stents by
Type, 2003 - 2013(US$)
- Figure 6-92 Swiss Market for Coronary Stents by Type, 2003 - 2013
- Figure 6-93 Swiss Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-94 Swiss Market for Bare-Metal Stents, 2003 - 2013 (€)
- Figure 6-95 Swiss Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-96 Leading Competitors, Swiss Market for Bare-Metal Stents, 2006
- Figure 6-97 Leading Competitors, Swiss Market for Drug-Eluting Stents,
2003 - 2013 (€)
- Figure 6-98 Leading Competitors, Swiss Market for Drug-Eluting Stents,
2003 - 2013 (US$)
- Figure 6-99 Leading Competitors, Swiss Market for Bare-Metal Stents, 2003
- 2013 (SFr.)
- Figure 6-100 Leading Competitors, Swiss Market for Drug-Eluting Stents,
2006
- Figure 6-101 Austrian Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-102 Austrian Market for Coronary by Type, 2003 - 2013(€)
- Figure 6-103 Austrian Market for Coronary Stents by Type, 2003 - 2013 (US$)
- Figure 6-104 Austrian Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-105 Austrian Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-106 Leading Competitors, Austrian Market for Bare-Metal Stents,
2006
- Figure 6-107 Austrian Market for Drug-Eluting Stents, 2003 - 2013 (€)
- Figure 6-108 Austrian Market for Drug-Eluting Stents, 2003 - 2013 (US$)
- Figure 6-109 Leading Competitors, Austrian Market for Drug-Eluting Stents,
2006
- Figure 6-110 Portuguese Market for Coronary Stents, Units per PCI
Procedure, 2003 - 2013
- Figure 6-113 Portuguese Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-114 Portuguese Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-115 Leading Competitors, Portuguese Market for Bare-Metal Stents,
2006
- Figure 6-118 Leading Competitors, Portuguese Market for Drug-Eluting
Stents, 2006
- Figure 6-119 Polish Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-120 Polish Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013 (€)
- Figure 6-121 Polish Market for Coronary Stents by Type, 2003 - 2013 (US$)
- Figure 6-122 Polish Market for Coronary Stents, by Type, 2003 - 2013
- Figure 6-123 Polish Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-124 Polish Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-125 Polish Market for Bare-Metal Stents, 2003 - 2013(z1)
- Figure 6-126 Leading Competitors, Polish Market for Bare-Metal Stents, 2006
- Figure 6-127 Polish Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-128 Polish Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-129 Polish Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-130 Leading Competitors, Polish Market for Drug-Eluting Stents,
2006
- Figure 7-1 European Market for PTCA Ballooon Catheters, 2003 - 2013(€)
- Figure 7-2 European Market for PTCA Ballooon Catheters, 2003 - 2013(US$)
- Figure 7-3 Market Drivers and Limiters, European Market for PTCA Balloon
Catheters, 2006
- Figure 7-4 Leading Competitors, European Market for PTCA Balloon
Catheters, 2006
- Figure 7-5 Units Sold, German Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-6 German Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-7 German Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-8 Leading Competitors, German Market for PTCA Balloon Catheters,
2006
- Figure 7-9 Units Sold, French Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-11 French Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-12 Leading Competitors, French Market for PTCA Balloon Catheters,
2006
- Figure 7-13 Units Sold, Italian Market for Balloon Catheters, 2003 - 2013
- Figure 7-14 Italian Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-15 Italian Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-16 Leading Competitors, Italian Market for PTCA Balloon
Catheters, 2006
- Figure 7-17 Units Sold, U.K. Market for PTCA Balloon Catheters, 2003 - 2013
- Figure 7-18 U.K. Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-19 U.K. Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-20 U.K. Market for PTCA Balloon Catheters, 2003 - 2013(£)
- Figure 7-21 Leading Competitors, U.K. Market for PTCA Balloon Catheters,
2006
- Figure 7-22 Units Sold, Spanish Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-23 Spanish Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-24 Spanish Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-25 Leading Competitors, Spanish Market for PTCA Balloon
Catheters, 2006
- Figure 7-26 Units Sold, Beneluxian Market for Balloon Catheters, 2003 -
2013
- Figure 7-27 Units Sold, Belgian Market for Balloon Catheters, 2003 - 2013
- Figure 7-28 Units Sold, Dutch Market for Balloon Catheters, 2003 - 2013
- Figure 7-29 Beneluxian Market for PTCA Balloon Catheters, 2003 -
2013(€)
- Figure 7-30 Beneluxian Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-31 Belgian Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-32 Belgian Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-33 Dutch Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-34 Dutch Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-35 Leading Competitors, Beneluxian Market for PTCA Balloon
Catheters, 2006
- Figure 7-36 Units Sold, Scandinavian Market for PTCA Balloon Catheters,
2003 - 2013
- Figure 7-37 Scandinavian Market for PTCA Balloon Catheters, 2003 -
2013(€)
- Figure 7-38 Scandinavian Market for PTCA Balloon Catheters, 2003 -
2013(US$)
- Figure 7-39 Leading Competitors, Scandinavian Market for PTCA Balloon
Catheters, 2006
- Figure 7-40 Units Sold, Swiss Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-41 Swiss Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-42 Swiss Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-43 Swiss Market for PTCA Balloon Catheters, 2003 - 2013(SFr.)
- Figure 7-44 Leading Competitors, Swiss Market for PTCA Balloon Catheters,
2006
- Figure 7-45 Units Sold, Austrian Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-46 Austrian Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-47 Austrian Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-48 Leading Competitors, Austrian Market for PTCA Balloon
Catheters, 2006
- Figure 7-49 Unit Sold, Portuguese Market for PTCA Balloon Catheters, 2003
- 2013
- Figure 7-50 Portuguese Market for PTCA Balloon Catheters, 2003 -
2013(€)
- Figure 7-51 Portuguese Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-52 Leading Competitors, Portuguese Market for PTCA Balloon
Catheters, 2006
- Figure 7-53 Units Sold, Polish Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-54 Polish Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-55 Polish Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-56 Polish Market for PTCA Balloon Catheters, 2003 - 2013(z1)
- Figure 7-57 Leading Competitors, Polish Market for PTCA Balloon Catheters,
2006
- Figure 8-1 European Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-2 European Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-3 Market Drivers, European Market for Interventional Catheters,
2006
- Figure 8-4 Market Limiters, European Market for Interventional Catheters,
2006
- Figure 8-5 Leading Competitors, European Market for Interventional
Catheters, 2006
- Figure 8-6 Units Sold, German market for Interventioanal Catheters, 2003 -
2013
- Figure 8-7 German Market for Interventioanal Catheters, 2003 - 2013(€)
- Figure 8-8 German Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-9 Leading Competitors, German Market for Interventional
Catheters, 2006
- Figure 8-10 Units Sold, French Market for Interventioanal Catheters, 2003
- 2013
- Figure 8-11 French Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-12 French Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-13 Leading Competitors, French Market for Interventional
Catheters, 2006
- Figure 8-14 Units Sold, Italian Market for Interventioanal Catheters, 2003
- 2013
- Figure 8-15 Italian Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-16 Italian Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-17 Leading Competitors, Italian Market for Interventional
Catheters, 2006
- Figure 8-18 Units Sold, U.K. Market for Interventioanal Catheters, 2003 -
2013
- Figure 8-19 U.K. Market for Interventioanal Catheters, 2003 - 2013(€)
- Figure 8-20 U.K. Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-21 U.K. Market for Interventioanal Catheters, 2003 - 2013(£)
- Figure 8-22 Leading Competitors, U.K. Market for Interventional Catheters,
2006
- Figure 8-23 Units Sold, Spanish Market for Interventioanal Catheters, 2003
- 2013
- Figure 8-24 Spanish Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-25 Spanish Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-26 Leading Competitors, Spanish Market for Interventional
Catheters, 2006
- Figure 8-27 Units Sold, Beneluxian Market for Interventioanal Catheters,
2003 - 2013
- Figure 8-28 Beneluxian Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-29 Beneluxian Market for Interventioanal Catheters, 2003 -
2013(US$)
- Figure 8-30 Leading Competitors, Beneluxian Market for Interventional
Catheters, 2006
- Figure 8-31 Units Sold, Scandinavian Market for Interventioanal Catheters,
2003 - 2013
- Figure 8-32 Scandinavian Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-33 Scandinavian Market for Interventioanal Catheters, 2003 -
2013(US$)
- Figure 8-34 Leading Competitors, Scandinavian Market for Interventional
Catheters, 2006
- Figure 8-35 Units Sold, Swiss Market for Interventioanal Catheters, 2003 -
2013
- Figure 8-36 Swiss Market for Interventioanal Catheters, 2003 - 2013(€)
- Figure 8-37 Swiss Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-38 Swiss Market for Interventioanal Catheters, 2003 - 2013(SFr.)
- Figure 8-39 Leading Competitors, Swiss Market for Interventional
Catheters, 2006
- Figure 8-40 Units Sold, Austrian Market for Interventioanal Catheters,
2003 - 2013
- Figure 8-41 Austrian Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-42 Austrian Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-43 Leading Competitors, Austrian Market for Interventional
Catheters, 2006
- Figure 8-44 Units Sold, Portuguese Market for Interventioanal Catheters,
2003 - 2013
- Figure 8-45 Portuguese Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-46 Portuguese Market for Interventioanal Catheters, 2003 -
2013(US$)
- Figure 8-47 Leading Competitors, Portuguese Market for Interventional
Catheters, 2006
- Figure 8-48 Units Sold, Polish Market for Interventioanal Catheters, 2003
- 2013
- Figure 8-49 Polish Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-50 Polish Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-52 Leading Competitors, Polish Market for Interventional
Catheters, 2006
- Figure 9-1 European Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 9-2 European Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 9-3 Market Drivers, European Market for Interventional Guidewires,
2006
- Figure 9-4 Market Limiters, European Market for Interventional Guidewires,
2006
- Figure 9-5 Leading Competitors, European Market for Interventional
Guidewires, 2006
- Figure 9-6 Units Sold, German Market for Interventional Guidewires, 2003 -
2013
- Figure 9-7 German Market for Interventional Guidewires, 2003 - 2013(€)
- Figure 9-8 German Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-9 Leading Competitors, German Market for Interventional
Guidewires, 2006
- Figure 9-10 Units Sold, French Market for Interventional Guidewires, 2003
- 2013
- Figure 9-11 French Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-12 French Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-13 Leading Competitors, French Market for Interventional
Guidewires, 2006
- Figure 9-14 Units Sold, Italian Market for Interventional Guidewires,
2003 - 2013
- Figure 9-15 Italian Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-16 Italian Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-17 Leading Competitors, Italian Market for Interventional
Guidewires, 2006
- Figure 9-18 Units Sold, U.K. Market for Interventional Guidewires, 2003 -
2013
- Figure 9-19 U.K. Market for Interventional Guidewires, 2003 - 2013(€)
- Figure 9-20 U.K. Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-21 U.K. Market for Interventional Guidewires, 2003 - 2013(£)
- Figure 9-22 Leading Competitors, U.K. Market for Interventional
Guidewires, 2006
- Figure 9-23 Units Sold, Spanish Market for Interventional Guidewires, 2003
- 2013(US$)
- Figure 9-24 Spanish Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-25 Spanish Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-26 Leading Competitors, Spanish Market for Interventional
Guidewires, 2006
- Figure 9-27 Units Sold, Beneluxian Market for Interventional Guidewires,
2003 - 2013
- Figure 9-28 Beneluxian Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-29 Beneluxian Market for Interventional Guidewires, 2003 -
2013(US$)
- Figure 9-30 Leading Competitors, Beneluxian Market for Interventional
Guidewires, 2006
- Figure 9-31 Units Sold, Scandinavian Market for Interventional Guidewires,
2003 - 2013
- Figure 9-32 Scandinavian Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-33 Scandinavian Market for Interventional Guidewires, 2003 -
2013(US$)
- Figure 9-34 Leading Competitors, Scandinavian Market for Interventional
Guidewires, 2006
- Figure 9-35 Units Sold, Swiss Market for Interventional Guidewires, 2003 -
2013
- Figure 9-36 Swiss Market for Interventional Guidewires, 2003 - 2013(€)
- Figure 9-37 Swiss Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-38 Swiss Market for Interventional Guidewires, 2003 - 2013(SFr.)
- Figure 9-39 Leading Competitors, Swiss Market for Interventional
Guidewires, 2006
- Figure 9-40 Units Sold, Austrian Market for Interventional Guidewires,
2003 - 2013
- Figure 9-41 Austrian Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-42 Austrian Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-43 Leading Competitors, Austrian Market for Interventional
Guidewires, 2006
- Figure 9-44 Units Sold, Portuguese Market for Interventional Guidewires,
2003 - 2013
- Figure 9-45 Portuguese Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-46 Portuguese Market for Interventional Guidewires, 2003 -
2013(US$)
- Figure 9-47 Leading Competitors, Portuguese Market for Interventional
Guidewires, 2006
- Figure 9-48 Units Sold, Polish Market for Interventional Guidewires, 2003
- 2013
- Figure 9-49 Polish Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-50 Polish Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-51 Polish Market for Interventional Guidewires, 2003 - 2013(z1)
- Figure 9-52 Leading Competitors, Polish Market for Interventional
Guidewires, 2006
- Figure 10-1 European Market for Introducer Sheaths, 2003 - 2013 (€)
- Figure 10-2 European Market for Introducer Sheaths, 2003 - 2013 (US$)
- Figure 10-3 European Market for Introducer Sheaths by Country 2003 - 2013
(€)
- Figure 10-4 European Market for Introducer Sheaths, by Country 2003 - 2013
(US$)
- Figure 10-5 European Market for Femoral Introducer Sheaths, 2003 - 2013
(€)
- Figure 10-6 European Market for Femoral Introducer Sheaths, 2003 - 2013
(US$)
- Figure 10-7 European Market for Transradial /Brachial Introducer Sheaths,
2003 - 2013 (€)
- Figure 10-8 European Market for Transradial /Brachial Introducer Sheaths,
2003 - 2013 (US$)
- Figure 10-9 Market Drivers and Limiters, European Market for Introducer
Sheaths, 2006
- Figure 10-10 Leading Competitors, European Market for Introducer Sheaths,
2006
- Figure 11-2 European Market for IVUS Catheters, 2003 - 2013(€)
- Figure 11-4 European Market for IVUS Catheters, 2003 - 2013(US$)
- Figure 11-5 Market Drivers, European Market for IVUS Catheters, 2006
- Figure 11-6 Market Limiters, European Market for IVUS Catheters, 2006
- Figure 11-7 Leading Competitors, European Market for IVUS Catheters, 2006
- Figure 12-1 European Market for Brachytherapy Catheters, 2003 -
2013(€)
- Figure 12-2 European Market for Brachytherapy Catheters, 2003 - 2013(US$)
- Figure 12-3 European Market for Brachytherapy Catheters, 2003 -
2013(€)
- Figure 12-4 European Market for Brachytherapy Catheters, 2003 - 2013(US$)
- Figure 12-5 Market Drivers and Limiters, European Market for Brachytherapy
Catheters, 2006
- Figure 12-6 Leading Competitors, European Market for Brachytherapy
Catheters, 2006
- Figure 13-1 European Market for Embolic Protection Devices, 2003 -
2013(€)
- Figure 13-2 European Market for Embolic Protection Devices, 2003 -
2013(US$)
- Figure 13-3 European Market for Embolic Protection Devices, 2003 -
2013(€)
- Figure 13-4 European Market for Embolic Protection Devices, 2003 - 2013
- Figure 13-5 Market Drivers and Limiters, European Market for Embolic
Protection Devices, 2006
- Figure 13-6 Leading Competitors, European Market for Embolic Protection
Devices, 2006
- Figure 14-1 European Market for Diagnostic Catheters and Guidewires by
Country, 2003 - 2013(€)
- Figure 14-2 European Market for Diagnostic Catheters and Guidewires by
Country, 2003 - 2013(US$)
- Figure 14-3 European Market for Diagnostic Catheters, 2003 - 2013(€)
- Figure 14-4 European Market for Diagnostic Catheters, 2003 - 2013(US$)
- Figure 14-5 European Market for Diagnostic Catheters, 2003 - 2013(€)
- Figure 14-6 European Market for Diagnostic Catheters, 2003 - 2013(US$)
- Figure 14-7 Market Drivers and Limiters, European Market for Diagnostic
Catheters and Guidewires, 2006
- Figure 14-8 Leading Competitors, Diagnostic Catheters and Guidewires, 2006
- Figure 15-1 Target Population, Potential European Market for Vulnerable
Plaque, 2009 - 2013
- Figure 15-2 Potential European Market for Vulnerable Plaque, Best-Case
Scenario, 2009 - 2013 (€)
- Figure 15-3 Potential European Market for Vulnerable Plaque, Best-Case
Scenario, 2009 - (US$)
- Figure 15-4 Potential European Market for Vulnerable Plaque Screening
Devices, Best-Case Senario, 2009 - 2013(€)
- Figure 15-5 Total Revenue, Potential European Market for Vulnerable Plaque
Screening Devices, Best-Case Scenario, 2009 - 2013(€)
- Figure 15-6 Potential European Market for Vulnerable Plaque Screeni ng
Devices, Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-7 Total Revenue, Potential European Market for Vulnerable Plaque
Screening Devices, Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-8 Potential European Market for Vulnerable Plaque Interventional
Devices, Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-9 Total Revenue, Potential European Market for Vulnerable Plaque
Interventional Devices, Best-Case Scenario, 2009 - 2013(€)
- Figure 15-10 Potential European Market for Vulnerable Plaque
Interventional Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-11 Total Revenue, Potential European Market for Vulnerable
Plaque Interventional Devices, Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-12 Market Players, Potential European Market for Vulnerable
Plaque Devices, 2009 - 2013
LIST OF CHARTS
- Chart 1-2 Fastest Growing Interventional Cardiology Markets, Segmented by
Country, 2003 - 2013
- Chart 1-3 Angioplasty Procedures, European Market for Interventional
Cardiology, 2003 - 2013
- Chart 1-4 Portuguese Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 1-5 European Market for Coronary Stents by Type, 2003 - 2013 (€)
- Chart 1-6 Leading Competitors, European Market for Interventional
Cardiology, 2006
- Chart 3-2 Fastest Growing Interventional Cardiology Markets, Segmented by
Country, 2003 - 2013
- Chart 3-3 Leading Competitors, European Market for Interventional
Cardiology 2006
- Chart 3-4 Market Concentrati on based on the Herfindahl Index , European
Market for Interventional Cardiology, 2003- 2013
- Chart 4-1 Angioplasty Procedures, European Market for Interventional
Cardiology 2003 - 2013
- Chart 5-1 German Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-2 French Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-3 Italian Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-4 The U.K. Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-5 Spanish Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-6 Beneluxian Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-7 Scandinavian Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-8 Swiss Price Index , DES Penetration, Population, GDP per Capita,
and PCI Penetration Rate, 2006
- Chart 5-9 Austrian Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-10 Portuguese Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-11 Polish Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 6-1 European Market for Coronary Stents by Type, 2003 - 2013 (€)
- Chart 6-2 European Penetration Rate for Coronary Stents by Type, Units
Sold, 2003 - 2013
- Chart 6-3 Penetration Rate by Country, European Market for Drug-Eluting
Stents, 2006 - 2007
- Chart 6-4 BMS Penetration Rate in Germany, 2003 - 2013
- Chart 6-5 DES Penetration Rate in Germany, 2003 - 2013
- Chart 6-6 BMS Penetration Rate in France, 2003 - 2013
- Chart 6-7 DES Penetration Rate in France, 2003 - 2013
- Chart 6-8 BMS Penetration Rate in Italy, 2003 - 2013
- Chart 6-9 DES Penetration Rate in Italy, 2003 - 2013
- Chart 6-10 BMS Penetraion Rate in United Kingdom, 2003 - 2013
- Chart 6-11 DES Penetraion Rate in United Kingdom, 2003 - 2013
- Chart 6-12 BMS Penetraion Rate in Spain, 2003 - 2013
- Chart 6-13 DES Penetraion Rate in Spain, 2003 - 2013
- Chart 6-14 Beneluzian Market for Coronary Stents by Type, 2003 - 2013
- Chart 6-15 BMS Penetraion Rate in Benelux, 2003 - 2013
- Chart 6-16 DES Penetration Rate in Benelux, 2003 - 2013
- Chart 6-17 BMS Penetration Rate in Scandinavia, 2003 - 2013
- Chart 6-18 DES Penetration Rate in Scandinavia, 2003 - 2013
- Chart 6-19 BMS Penetration Rate in Switzerland, 2003 - 2013
- Chart 6-20 DES Penetration Rate in Switzerland, 2003 - 2013
- Chart 6-21 BMS Penetration Rate in Austria, 2003 - 2013
- Chart 6-22 DES Penetration Rate in Austria, 2003 - 2013
- Chart 6-23 BMS Penetration Rate in Portugal, 2003 - 2013
- Chart 6-24 DES Penetration Rate in Portugal, 2003 - 2013
- Chart 6-25 BMS Penetration Rate in Poland, 2003 - 2013
- Chart 6-26 DES Penetration Rate in Poland, 2003 - 2013
- Chart 7-1 European Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Chart 8-1 European Market Interventional Catheters, 2003 - 2013 (€)
- Chart 9-1 European Market Interventional Guidewires, 2003 - 2013 (€)
- Chart 13-1 European Market for Embolic Protection Devices, 2003 - 2013
- Chart 14-1 European Market for Diagnostic Catheters and Guidewires, 2003 -
2013
- Chart 14-2 European Market for Diagnostic Catheters, 2003 - 2013
- Chart 14-3 European Market for Diagnostic Guidewires, 2003 - 2013
- Chart 15-1 Potential European Market for Vulnerable Plaque, Best-Case
Scenario, 2009
- Chart 15-2 Total Revenue Probability, Potential European Market for
Vulnerable Plaque Devices (Screening and Interconventional), 2009 - 2013
|
